Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kirschmeier

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of Biomolecular NMR|March 1, 1996
Chemical shift assignments and secondary structure of the Grb2 SH2 domain by heteronuclear NMR spectroscopyY S Wang, A F Frederick, M M Senior, et al.
The Journal of Biological Chemistry|September 26, 2001
Analyses of p53 target genes in the human genome by bioinformatic and microarray approachesL Wang, Q Wu, P Qiu, et al.
The Journal of Biological Chemistry|May 30, 1997
K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitorsD B Whyte, P Kirschmeier, T N Hockenberry, et al.
Blood|February 27, 2001
Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemiaD G Peters, R R Hoover, M J Gerlach, et al.
The Journal of Biological Chemistry|April 11, 1997
Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type IF L Zhang, P Kirschmeier, D Carr, et al.
Bioorganic & Medicinal Chemistry|July 10, 1999
Atropisomeric trihalobenzocycloheptapyridine analogues provide stereoselective FPT inhibitors with antitumor activityF G Njoroge, B Vibulbhan, W R Bishop, et al.
Experimental Cell Research|December 20, 2000
The farnesyl transferase inhibitor SCH 66336 induces a G(2) --> M or G(1) pause in sensitive human tumor cell linesH R Ashar, L James, K Gray, et al.
Cancer Research|April 15, 2000
A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activityA A Adjei, C Erlichman, J N Davis, et al.
Bioorganic & Medicinal Chemistry|January 1, 1997
Discovery of novel nonpeptide tricyclic inhibitors of Ras farnesyl protein transferaseF G Njoroge, R J Doll, B Vibulbhan, et al.
Bioorganic & Medicinal Chemistry|May 1, 1997
Detection and structural characterization of ras oncoprotein-inhibitors complexes by electrospray mass spectrometryA K Ganguly, B N Pramanik, E C Huang, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Biomolecular NMR|March 1, 1996
Chemical shift assignments and secondary structure of the Grb2 SH2 domain by heteronuclear NMR spectroscopyY S Wang, A F Frederick, M M Senior, et al.
The Journal of Biological Chemistry|September 26, 2001
Analyses of p53 target genes in the human genome by bioinformatic and microarray approachesL Wang, Q Wu, P Qiu, et al.
The Journal of Biological Chemistry|May 30, 1997
K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitorsD B Whyte, P Kirschmeier, T N Hockenberry, et al.
Blood|February 27, 2001
Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemiaD G Peters, R R Hoover, M J Gerlach, et al.
The Journal of Biological Chemistry|April 11, 1997
Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type IF L Zhang, P Kirschmeier, D Carr, et al.
Bioorganic & Medicinal Chemistry|July 10, 1999
Atropisomeric trihalobenzocycloheptapyridine analogues provide stereoselective FPT inhibitors with antitumor activityF G Njoroge, B Vibulbhan, W R Bishop, et al.
Experimental Cell Research|December 20, 2000
The farnesyl transferase inhibitor SCH 66336 induces a G(2) --> M or G(1) pause in sensitive human tumor cell linesH R Ashar, L James, K Gray, et al.
Cancer Research|April 15, 2000
A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activityA A Adjei, C Erlichman, J N Davis, et al.
Bioorganic & Medicinal Chemistry|January 1, 1997
Discovery of novel nonpeptide tricyclic inhibitors of Ras farnesyl protein transferaseF G Njoroge, R J Doll, B Vibulbhan, et al.
Bioorganic & Medicinal Chemistry|May 1, 1997
Detection and structural characterization of ras oncoprotein-inhibitors complexes by electrospray mass spectrometryA K Ganguly, B N Pramanik, E C Huang, et al.
Pageof 4